301
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs

, , , , , , & show all
Pages 51-62 | Received 16 Jun 2013, Accepted 15 Sep 2013, Published online: 10 Oct 2013

References

  • Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603–16
  • Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007;59:617–30
  • Shegokarand R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129–39
  • Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008;70:439–44
  • Muela S, Escalera B, Peña MÁ, Bustamante P. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents. Int J Pharm 2010;384:93–9
  • Nielsen AB, Frydenvang K, Liljefors T, et al. Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug. Eur J Pharm Sci 2005;24:85–93
  • Riekes MK, Tagliari MP, Granada A, et al. Enhanced solubility and dissolution rate of amiodarone by complexation with [beta]-cyclodextrin through different methods. Mat Sci Eng: C 2010;30:1008–13
  • Srinarong P, Faber JH, Visser MR, et al. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 2009;73:154–61
  • Unga J, Tajarobi F, Norder O, et al. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions. Eur J Pharm Biopharm 2009;73:260–8
  • Ticehurst MD, Basford PA, Dallman CI, et al. Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. Int J Pharm 2000;193:247–59
  • Figuerola A, Di Corato R, Manna L, Pellegrino T. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 2010;62:126–43
  • Xu Y, Ding W, Liu J, et al. Preparation and characterization of organic-soluble acetylated starch nanocrystals. Carbohydr Polymer 2010;80:1078–84
  • Xiao Y, Liu F, Ping Q, Cai H. The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil. Drug Dev Ind Pharm 2012;38:1521–9
  • Kim GG, Poudel BK, Marasini N, et al. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2013;39:1431–8
  • Parreen R, Ahmad FJ, Iqbal Z, et al. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm 2013;39:1–7
  • Chen S, Liu W, Wan J, et al. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm 2013;39:20–8
  • Vanić Z, Hafner A, Bego M, Škalko-Basnet N. Characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm 2013;39:481–8
  • Qu C, Ni J, Yang P, et al. Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia–reperfusion. Drug Dev Ind Pharm 2013;39:1291–5
  • Wang M, Yuan Y, Gao Y, et al. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo. Drug Dev Ind Pharm 2012;38:1134–41
  • Akhter S, Kushwaha S, Warsi MH, et al. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Drug Dev Ind Pharm 2012;38:84–92
  • Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008;361:104–11
  • Huand C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm 1999;185:23–35
  • Veerareddy PR, Bobbala SK. Enhanced oral bioavailability of isradipine via proniosomal systems. Drug Dev Ind Pharm 2013;39:909–17
  • Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005;59:485–90
  • Fang J-Y, Yu S-Y, Wu P-C, et al. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 2001;215:91–9
  • Doelker E. Pharmaceutical dosage forms: tablets. J Control Release 1991;15:185
  • Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 2006;114:53–9
  • Mura S, Manconi M, Sinico C, et al. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009;380:72–9
  • Luo Q, Zhao J, Zhang X, Pan W. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 2011;403:185–91
  • Xu H, He L, Nie S, et al. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release 2009;140:61–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.